Johnson & Johnson falls short in a Remicade patent case as star drug slips in Q4

24th January 2018 Uncategorised 0

With billions on the line between pharma giants Johnson & Johnson and Pfizer, an appeals panel upheld a decision to invalidate a key Remicade patent.

More: Johnson & Johnson falls short in a Remicade patent case as star drug slips in Q4
Source: fierce